Overview Among the powerful new features in Python 3.14 is a new interface for attaching a live debugger to a running Python program. You can inspect the state of a Python app, make changes, ...

Leerink analyst Jonathan Chang upgraded Replimune (REPL) to Outperform from Market Perform with a price target of $13, up from $3, after FDA accepted the application resubmission of RP1 plus nivolumab ...

The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $10.84 / share. This is an increase of 48.75% from the prior estimate of $7.29 dated September 27, 2025. The ...

In a report released today, Peter Lawson from Barclays maintained a Hold rating on Replimune Group, with a price target of $3.00. The company’s shares closed yesterday at $8.95. Take advantage of ...

Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

[bogdanthegeek] has a lot of experience with the ARM platform, and their latest escapade into working with cheap ARM chips recovered from disposable vapes involved a realization that it was just plain ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in UnitedHealth Group Inc (Symbol: UNH), where a total volume of 92,988 contracts has ...

For nearly 200 years our valley campus has kindled an ideal environment to ignite potential and change lives. We give students an uncommon set of top-ranked programs. Mix and match courses in the ...